New Cousteau-Linked...
Array BioPharma Inc. (ARRY: NASDAQ)
$3.38 -0.04 | -1.17%
06/04/12 - 04:00 PM ET
Company Income Statement
| Jun 2011 | Jun 2010 | Jun 2009 | Jun 2008 | |
| Sales | 71.90M | 53.88M | 24.98M | 28.81M |
| Cost of Sales | 21.30M | 21.98M | 13.24M | 14.32M |
| Gross Operating Profit | 50.60M | 31.90M | 11.74M | 14.49M |
| Selling, General, and Administrative Expenses | 16.26M | 17.12M | 18.02M | 15.59M |
| Research & Development | 63.50M | 72.49M | 89.56M | 90.35M |
| Operating Income before D & A (EBITDA) | -29.16M | -57.71M | -95.84M | -91.45M |
| Depreciation & Amortization | 7.62M | 6.34M | 6.61M | 7.05M |
| Interest Income | 406.00K | 864.00K | 2.12M | 6.06M |
| Other Income - Net | -4.45M | 1.30M | -17.74M | 0.00 |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | -1.87M |
| Total Income Before Interest Expenses (EBIT) | -40.82M | -61.88M | -118.08M | -94.30M |
| Interest Expense | 15.51M | 15.75M | 10.02M | 1.99M |
| Pre-Tax Income | -56.32M | -77.63M | -128.10M | -96.29M |
| Income Taxes | 0.00 | 0.00 | -288.00K | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -56.32M | -77.63M | -127.82M | -96.29M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -56.32M | -77.63M | -127.82M | -96.29M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -56.32M | -77.63M | -127.82M | -96.29M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-56.32M | -77.63M | -127.82M | -94.42M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -56.32M | -77.63M | -127.82M | -96.29M |
| Basic EPS from Continuing Ops. | -1.02 | -1.55 | -2.67 | -2.04 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -1.02 | -1.55 | -2.67 | -2.04 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -1.02 | -1.55 | -2.67 | -2.04 |
| Basic Normalized Net Income/Share | -1.02 | -1.55 | -2.67 | -2.00 |
| EPS fr Continuing Ops. | -1.02 | -1.55 | -2.67 | -2.04 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -1.02 | -1.55 | -2.67 | -2.04 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -1.02 | -1.55 | -2.67 | -2.04 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-1.02 | -1.55 | -2.67 | -2.00 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with ARRY
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- Contributor7 Cancer Drug Stocks to Kno...
- ContributorStocks Under-$10 Moving Hig...
- ContributorUnder-$10 Setting Up To Tra...
- UserASCO 2010
- ContributorBarron's Activist Stocks 1-...
- UserPART 6 JPMorgan 28th Annual...
- ContributorBarron's Activist Stocks 1-...
- ContributorBarron's Activist Stocks 1-...
Latest ARRY Headlines from TheStreet
- ASCO 2012 Live Blog -- Monday 06.04.12 | 06:06 am
- Biotech Stock Mailbag: ASCO, Celldex, Obesity Drug Game-Changer 05.25.12 | 05:05 am
- The Next Big Thing in Biotech: ASCO Conference
05.25.12 | 05:05 am - 7 Stocks Under $10 Making Big Moves 05.17.12 | 12:05 pm
- Biotech Stock Live Chat Recap: ASCO & Obesity 05.17.12 | 11:05 am
- ASCO '12 Abstract Dump: Cancer Stocks in Focus (Update) 05.17.12 | 06:05 am
- ASCO '12 Abstract Dump: Cancer Stocks in Focus 05.16.12 | 06:05 pm
- Hot Biotech Stocks Traded by Hedge Funds in First Quarter 05.16.12 | 07:05 am
- 7 Cancer Drug Stocks to Know Right Now 03.14.12 | 09:03 am
- Array BioPharma Stock Gaps Down On Today's Open (ARRY) 02.09.12 | 08:02 am
Press Releases for ARRY
- Promising Data For KRAS Mutant Advanced NSCLC Patients Presented At ASCO - Business Wire 06.04.12 | 05:06 pm
- MEK162 Shows Promising Clinical Activity In Ongoing Phase 2 Trial - Business Wire 06.04.12 | 04:06 pm
- Array BioPharma To Present At The Jefferies 2012 Global Healthcare Conference - Business Wire 05.30.12 | 03:05 pm
- Array BioPharma And Genentech's Strategic Alliance Voted Breakthrough Alliance Of 2012 - Business Wire 05.14.12 | 06:05 pm
- Liam Ratcliffe, M.D., Ph.D., Independent Director, Array BioPharma Board Of Directors (Photo: Business Wire) - Business Wire 04.30.12 | 08:04 am
- Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2012 On April 30, 2012 - Business Wire 04.23.12 | 04:04 pm
- Array BioPharma Names Howard Holden, Ph.D., Vice President Of Regulatory Affairs And Quality Assurance - Business Wire 04.16.12 | 08:04 am
- Encouraging Selumetinib Results Announced For Phase 2 Trial In Ovarian Cancer - Business Wire 04.04.12 | 09:04 am
- Array BioPharma To Present At The Cowen And Company 32nd Annual Health Care Conference - Business Wire 02.27.12 | 01:02 pm
- Array BioPharma Announces Closing Of Public Offering Of Common Stock And Exercise Of Overallotment Option - Business Wire 02.14.12 | 09:02 am
Partner Headlines for ARRY
- Array BioPharma Says Encouraging Selumetinib Results Announced for Phase 2 Trial in Ovarian Cancer - Benzinga 04.04.12 | 09:04 am
- Company News for February 10, 2012 - Corporate Summary - Zacks 02.10.12 | 10:02 am
- Biotech Stocks To Watch In 2012 - Seeking Alpha 02.06.12 | 09:02 am
- Array BioPharma Names Gwen A. Fyfe, M.D. to Board of Directors - Benzinga 01.30.12 | 04:01 pm
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 11.03.11 | 09:11 am
- Bottom Bounce for Array BioPharma - Seeking Alpha 06.29.11 | 09:06 am
- Future Biotech Superstars - Seeking Alpha 03.30.11 | 09:03 am
- How Array Got Its Groove Back - SeekingAlpha.com 04.28.10 | 01:04 pm
- Biotech Gets Busy With Small Company Financings - SeekingAlpha.com 04.25.10 | 08:04 am
- Array and Novartis Ink Deal - Analyst Blog - Zacks 04.22.10 | 02:04 pm





